ABOUT ALMAC CLINICAL TECHNOLOGIES
Almac Clinical Technologies is a trusted partner providing industry-leading clinical trial technology, expertise, and seamless service at every stage of the participant journey. Supporting biopharmaceutical sponsors and CROs in accelerating drug development through its industry-leading Interactive Response Technology (IRT) and integrated electronic Clinical Outcome Assessment (eCOA) platform.
With a steadfast commitment to quality, Almac embeds compliance, precision, and reliability into every phase of the clinical trial process. Its solutions streamline site, patient, and supply management while delivering real-time data and intuitive tools that enable informed, data-driven decisions and enhance global participant engagement.
FEATURED ARTICLES
-
Clear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.
-
Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.
-
Learn why sponsors should implement an integrated data monitoring plan and technology solution to ensure data integrity, meet evolving regulatory requirements, and improve trial outcomes.
-
From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.
-
The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
-
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
The future lies in unified, interoperable eCOA–IRT solutions that streamline operations, improve data integrity, and enhance patient and site experience.
-
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
CONTACT INFORMATION
Almac Clinical Technologies
20 Seagoe Industrial Estate
Craigavon, BT63 5QD
UNITED KINGDOM
FEATURED SOLUTIONS
-
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
-
From signature to re-consent, manual processes add delay and risk. Discover how a digital approach to informed consent keeps studies compliant, on track, and participant-focused.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.
-
Rapidly reduced timelines and waste, and the prevention of costly product shortages
In a world that is constantly changing, the development of innovative personalised medicine is helping more of us to live healthier lives for longer. These leaps forward in drug development create new hope for patients.
Yet operating high-value, time-sensitive supply chains naturally brings additional challenge and risk. Challenge and risk that require a step change in production approach to effectively balance patient-centricity with commercial viability.
-
Almac Trial Coordinator™ is a unified eClinical orchestration solution designed to simplify the execution of complex clinical trials. It brings together core trial functions including Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, visit and participant management, and clinical supply oversight within a single, cohesive ecosystem.
Rather than operating as a collection of disconnected point solutions, Almac Trial Coordinator™ is designed to coordinate workflows, data, and users across the clinical trial lifecycle. The result is a more efficient, transparent, and site-friendly way to run global studies.
-
Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
-
This scalable, participant-centric solution strengthens site efficiency and supports sponsors in executing complex clinical studies with confidence.
-
High-quality outcome data is essential to clinical trial success, and this eCOA solution provides participant-first design features while supporting multiple modalities.
CASE STUDIES
-
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.